Chemicals · Founded 1955 · www.keva.co.in · BSE 539450 · NSE SHK · ISIN INE500L01026
No Notes Added Yet
Business
SH Kelkar And Company Ltd. (SHK) is a leading Indian manufacturer and supplier of fragrances, flavors, and aroma chemicals. The company operates as a business-to-business (B2B) supplier, creating and producing complex blends used by a wide array of industries. Their fragrances are used in personal care products (soaps, shampoos, deodorants), home care products (detergents, cleaners), fabric care, fine fragrances, and incense sticks. Their flavors find application in food and beverages, confectioneries, dairy products, and pharmaceuticals. SHK makes money by leveraging its R&D capabilities, creative design studios, and manufacturing infrastructure to develop and sell these specialized compounds to fast-moving consumer goods (FMCG) companies, pharmaceutical firms, and other industrial clients, helping them differentiate their end products.
Revenue Mix
SH Kelkar's primary business segments are:
Fragrances: This segment typically contributes the larger portion of the revenue, catering to industries like personal care, home care, and fine fragrances.
Flavors: This segment caters to the food and beverage industry, including confectionery, dairy, and snack food manufacturers.
Aroma Chemicals: The company also manufactures certain key aroma chemicals, which can be used internally for their own blends or sold to other customers.
While specific revenue percentages fluctuate, fragrances generally form the dominant segment, followed by flavors. The company has a presence in both the Indian market and international markets (e.g., Indonesia, UAE, Netherlands).
Industry
The global flavors and fragrances industry is characterized by a few large multinational players (e.g., Givaudan, IFF, Firmenich, Symrise) and numerous smaller, regional companies. It's an R&D-intensive industry driven by consumer trends and the need for new sensory experiences. SHK is positioned as a leading Indian player in this industry, competing with both global giants' local operations and other smaller domestic players. They leverage their understanding of local tastes and preferences, agile product development, and cost-effective manufacturing to serve a diverse customer base, from large FMCG corporations to regional brands and contract manufacturers. The industry benefits from growth in consumer products, particularly in emerging markets.
MOAT
SH Kelkar possesses several competitive advantages:
R&D and Creative Expertise: The ability to consistently develop new and appealing fragrances and flavors that resonate with evolving consumer preferences is a significant differentiator. They have dedicated design studios and R&D facilities.
Customer Stickiness/Switching Costs: Once a specific flavor or fragrance is integrated into a customer's product and becomes successful, switching to a different supplier can be complex, costly, and risky (due to reformulation, regulatory hurdles, and potential consumer rejection). This creates high switching costs.
Scale and Market Share in India: Being a leading domestic player provides certain scale advantages in procurement, manufacturing, and distribution within India.
Understanding of Local Tastes: Deep insight into the Indian consumer palate and olfactive preferences is crucial in developing successful products for the local market.
Backward Integration: Manufacturing some key aroma chemicals provides a degree of control over raw material quality and supply chain stability.
Growth Drivers
Growing FMCG Market: Continued growth in the Indian and other emerging market FMCG sectors (personal care, home care, food & beverages) directly translates to higher demand for fragrances and flavors.
Premiumization Trend: Increasing consumer disposable income and a desire for premium products drive demand for sophisticated and higher-value fragrances and flavors.
New Product Development & Innovation: Continuous investment in R&D to create novel and trending olfactory and gustatory experiences will enable market share gains.
Geographic Expansion: Further penetration into international markets, particularly in Asia and the Middle East, can open new revenue streams.
Acquisitions: Strategic acquisitions of smaller players or specialized capabilities can enhance market presence and product portfolio.
Health and Wellness Trends: Growing demand for natural, organic, or functional ingredients in flavors and fragrances.
Risks
Raw Material Price Volatility: The company relies on both natural and synthetic raw materials, whose prices and availability can be subject to geopolitical events, weather conditions, and commodity market fluctuations, impacting margins.
Intense Competition: The industry is competitive, with large global players having significant R&D budgets and economies of scale, and smaller players offering aggressive pricing.
R&D Success Dependence: The ability to consistently innovate and create popular fragrances and flavors is critical. Failure to do so can lead to loss of market share.
Regulatory Changes: Stricter regulations regarding ingredient safety, environmental impact, or labeling in key markets could necessitate costly reformulations or product withdrawals.
Economic Slowdown: A downturn in consumer spending, especially in discretionary FMCG categories, could impact demand for their products.
Foreign Exchange Fluctuations: As the company has international operations and sources raw materials globally, adverse currency movements can impact profitability.
Management & Ownership
SH Kelkar And Company Ltd. is largely promoter-driven, with the Kelkar family holding a significant stake and active management roles. The company was founded by the Kelkar family, bringing decades of experience in the flavors and fragrances industry. Mr. Ramesh V. Vaze (Group CEO) and Mrs. Kedar Vaze (Whole-Time Director & CEO) are key figures from the promoter group. The ownership structure includes the promoter group, institutional investors (domestic and foreign), and the public, indicating a blend of stable long-term ownership and market participation.
Outlook
SH Kelkar operates in a growing industry driven by evolving consumer preferences and the expanding FMCG market, particularly in India and other developing economies. The company's established market position, R&D capabilities, and understanding of local tastes are strong advantages. The bull case rests on the continued growth of consumer product markets, successful new product innovations, and effective geographic expansion, allowing SHK to capture increasing market share and improve profitability. However, the bear case highlights significant risks from volatile raw material prices, intense competition from global giants, and the inherent challenges of continuous innovation. An inability to consistently develop winning formulations or adapt to changing regulatory landscapes could pressure margins and growth. The company's performance will largely depend on its ability to navigate these competitive and operational challenges while capitalizing on underlying consumer demand trends.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 472 | 513 | 470 | 543 | 543 | 567 | 581 | 554 | 584 | 650 |
| Other Income | 2 | 1 | 1 | 21 | 1 | 2 | 1 | 0 | 1 | 7 |
| Total Income | 474 | 515 | 471 | 563 | 544 | 569 | 581 | 554 | 585 | 657 |
| Total Expenditure | 396 | 424 | 392 | 462 | 479 | 494 | 508 | 501 | 528 | 590 |
| Operating Profit | 78 | 91 | 79 | 101 | 65 | 75 | 74 | 53 | 57 | 67 |
| Interest | 10 | 10 | 10 | 13 | 14 | 13 | 13 | 14 | 14 | 15 |
| Depreciation | 22 | 22 | 22 | 24 | 23 | 25 | 26 | 27 | 27 | 39 |
| Exceptional Income / Expenses | 0 | 0 | -120 | 0 | 0 | 59 | 2 | 1 | 33 | 0 |
| Profit Before Tax | 46 | 59 | -73 | 64 | 28 | 97 | 36 | 12 | 50 | 14 |
| Provision for Tax | 14 | 24 | 12 | 24 | 10 | -6 | 11 | 3 | 16 | 13 |
| Profit After Tax | 32 | 35 | -86 | 40 | 18 | 102 | 25 | 9 | 33 | 1 |
| Adjustments | -0 | -1 | -1 | -1 | -1 | 0 | 0 | -0 | -1 | 1 |
| Profit After Adjustments | 32 | 34 | -87 | 40 | 18 | 103 | 26 | 9 | 33 | 2 |
| Adjusted Earnings Per Share | 2.3 | 2.4 | -6.3 | 2.9 | 1.3 | 7.4 | 1.8 | 0.7 | 2.4 | 0.1 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 836 | 925 | 981 | 1021 | 1048 | 1114 | 1322 | 1564 | 1687 | 1841 | 2123 | 2369 |
| Other Income | 68 | 10 | 12 | 26 | 23 | 8 | 23 | 18 | 17 | 6 | 24 | 9 |
| Total Income | 903 | 935 | 992 | 1047 | 1071 | 1122 | 1345 | 1582 | 1703 | 1847 | 2147 | 2377 |
| Total Expenditure | 760 | 774 | 814 | 862 | 910 | 955 | 1083 | 1350 | 1474 | 1538 | 1826 | 2127 |
| Operating Profit | 143 | 162 | 178 | 185 | 162 | 167 | 263 | 232 | 229 | 309 | 321 | 251 |
| Interest | 19 | 22 | 6 | 5 | 16 | 26 | 20 | 16 | 24 | 40 | 49 | 56 |
| Depreciation | 29 | 30 | 19 | 24 | 31 | 52 | 62 | 72 | 80 | 86 | 95 | 119 |
| Exceptional Income / Expenses | 0 | 0 | 0 | -13 | 0 | -36 | 13 | -12 | -20 | 0 | -61 | 36 |
| Profit Before Tax | 95 | 110 | 153 | 143 | 115 | 54 | 194 | 132 | 104 | 183 | 115 | 112 |
| Provision for Tax | 24 | 37 | 48 | 51 | 27 | 19 | 50 | -17 | 41 | 59 | 41 | 43 |
| Profit After Tax | 70 | 73 | 105 | 93 | 88 | 36 | 144 | 149 | 63 | 124 | 74 | 68 |
| Adjustments | 0 | 0 | 0 | 1 | 1 | -0 | 1 | -1 | -2 | -1 | -1 | 0 |
| Profit After Adjustments | 70 | 73 | 105 | 94 | 88 | 36 | 145 | 149 | 61 | 122 | 73 | 70 |
| Adjusted Earnings Per Share | 5.3 | 5.1 | 7.2 | 6.5 | 6.1 | 2.5 | 10.2 | 10.7 | 4.4 | 8.8 | 5.3 | 5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 15% | 11% | 14% | 10% |
| Operating Profit CAGR | 4% | 11% | 14% | 8% |
| PAT CAGR | -40% | -21% | 16% | 1% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -42% | 8% | -2% | -5% |
| ROE Average | 6% | 8% | 11% | 11% |
| ROCE Average | 8% | 10% | 11% | 13% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 510 | 716 | 812 | 857 | 863 | 824 | 952 | 1013 | 1064 | 1213 | 1272 |
| Minority's Interest | 0 | 0 | 0 | 0 | 11 | 11 | 3 | 80 | 38 | 1 | 0 |
| Borrowings | 39 | 30 | 9 | 48 | 70 | 54 | 332 | 363 | 319 | 173 | 175 |
| Other Non-Current Liabilities | 6 | 7 | 5 | 83 | 55 | -7 | 14 | 97 | 72 | 59 | 81 |
| Total Current Liabilities | 380 | 250 | 247 | 412 | 541 | 575 | 574 | 725 | 709 | 934 | 1131 |
| Total Liabilities | 934 | 1003 | 1073 | 1400 | 1541 | 1457 | 1874 | 2279 | 2202 | 2381 | 2660 |
| Fixed Assets | 274 | 227 | 296 | 338 | 448 | 459 | 728 | 946 | 913 | 933 | 952 |
| Other Non-Current Assets | 45 | 50 | 80 | 316 | 261 | 190 | 102 | 100 | 82 | 85 | 132 |
| Total Current Assets | 615 | 726 | 697 | 746 | 831 | 781 | 1016 | 1232 | 1207 | 1363 | 1576 |
| Total Assets | 934 | 1003 | 1073 | 1400 | 1541 | 1457 | 1874 | 2279 | 2202 | 2381 | 2660 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 35 | 72 | 59 | 42 | 11 | -1 | -33 | 102 | 31 | -57 | -21 |
| Cash Flow from Operating Activities | 62 | 86 | 102 | 103 | 77 | 205 | 195 | 50 | 197 | 107 | 16 |
| Cash Flow from Investing Activities | -17 | -77 | -104 | -164 | -137 | -40 | -149 | -160 | -103 | -82 | -72 |
| Cash Flow from Financing Activities | -7 | -24 | -16 | 28 | 49 | -196 | 88 | 12 | -175 | 8 | 99 |
| Net Cash Inflow / Outflow | 37 | -14 | -17 | -33 | -11 | -31 | 134 | -97 | -81 | 34 | 43 |
| Closing Cash & Cash Equivalent | 72 | 59 | 42 | 11 | -1 | -33 | 102 | 31 | -57 | -25 | 20 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 5.32 | 5.05 | 7.25 | 6.49 | 6.12 | 2.53 | 10.24 | 10.73 | 4.42 | 8.84 | 5.29 |
| CEPS(Rs) | 7.54 | 7.1 | 8.59 | 8.05 | 8.23 | 6.18 | 14.54 | 15.98 | 10.36 | 15.16 | 12.19 |
| DPS(Rs) | 1.13 | 1.5 | 1.75 | 1.75 | 0 | 0.95 | 1.75 | 0.75 | 2 | 0.75 | 1 |
| Book NAV/Share(Rs) | 37.84 | 49.51 | 56.13 | 59.25 | 59.7 | 58.31 | 67.34 | 73.2 | 76.9 | 87.62 | 91.89 |
| Core EBITDA Margin(%) | 8.5 | 15.18 | 15.66 | 15.27 | 13.12 | 14.19 | 17.97 | 13.56 | 12.48 | 16.27 | 13.87 |
| EBIT Margin(%) | 12.85 | 13.25 | 14.92 | 14.22 | 12.38 | 7.15 | 16.07 | 9.42 | 7.53 | 11.99 | 7.67 |
| Pre Tax Margin(%) | 10.66 | 11.08 | 14.33 | 13.71 | 10.91 | 4.86 | 14.54 | 8.39 | 6.13 | 9.85 | 5.36 |
| PAT Margin (%) | 7.94 | 7.34 | 9.83 | 8.87 | 8.34 | 3.2 | 10.82 | 9.48 | 3.7 | 6.65 | 3.46 |
| Cash Profit Margin (%) | 11.24 | 10.32 | 11.66 | 11.15 | 11.3 | 7.79 | 15.44 | 14.03 | 8.42 | 11.28 | 7.88 |
| ROA(%) | 7.85 | 7.54 | 10.1 | 7.49 | 5.97 | 2.39 | 8.64 | 7.2 | 2.81 | 5.4 | 2.94 |
| ROE(%) | 14.36 | 12.01 | 13.72 | 11.1 | 10.21 | 4.25 | 16.22 | 15.21 | 6.06 | 10.87 | 5.96 |
| ROCE(%) | 15.78 | 16.97 | 18.84 | 15.5 | 11.67 | 6.7 | 16.08 | 9.48 | 7.75 | 12.78 | 8.45 |
| Receivable days | 76.94 | 77.62 | 76.34 | 86.3 | 97.23 | 97.91 | 94.9 | 96.75 | 96.45 | 91.02 | 84.83 |
| Inventory Days | 122.72 | 119.69 | 117.36 | 122.04 | 125.1 | 115.65 | 105.12 | 114 | 124.22 | 123.61 | 117.14 |
| Payable days | 76.03 | 95.79 | 96.62 | 89.27 | 92.62 | 91.79 | 105.93 | 121.59 | 135.7 | 131.88 | 119.13 |
| PER(x) | 0 | 44.83 | 41.09 | 39.81 | 25.08 | 30.73 | 10.91 | 13.37 | 22.48 | 23.21 | 33.59 |
| Price/Book(x) | 0 | 4.57 | 5.31 | 4.36 | 2.57 | 1.33 | 1.66 | 1.96 | 1.29 | 2.34 | 1.93 |
| Dividend Yield(%) | 0 | 0.66 | 0.59 | 0.68 | 0 | 1.22 | 1.57 | 0.52 | 2.01 | 0.37 | 0.56 |
| EV/Net Sales(x) | 0.37 | 3.55 | 4.41 | 3.81 | 2.4 | 1.25 | 1.48 | 1.61 | 1.12 | 1.83 | 1.48 |
| EV/Core EBITDA(x) | 2.15 | 20.3 | 24.25 | 20.99 | 15.6 | 8.36 | 7.46 | 10.83 | 8.24 | 10.91 | 9.79 |
| Net Sales Growth(%) | 9.74 | 10.69 | 6.02 | 4.13 | 2.65 | 6.31 | 18.64 | 18.32 | 7.82 | 9.15 | 15.35 |
| EBIT Growth(%) | -5.47 | 15.72 | 20.57 | -6.64 | -12.15 | -38.47 | 166.43 | -30.48 | -13.6 | 73.92 | -26.37 |
| PAT Growth(%) | -11.02 | 3.78 | 43.47 | -11.68 | -5.12 | -59.18 | 301.48 | 3.96 | -57.87 | 96.66 | -40.16 |
| EPS Growth(%) | -2.12 | -5.08 | 43.47 | -10.44 | -5.75 | -58.72 | 305.4 | 4.83 | -58.83 | 100.13 | -40.17 |
| Debt/Equity(x) | 0.48 | 0.12 | 0.09 | 0.2 | 0.4 | 0.44 | 0.54 | 0.64 | 0.55 | 0.52 | 0.6 |
| Current Ratio(x) | 1.62 | 2.9 | 2.82 | 1.81 | 1.54 | 1.36 | 1.77 | 1.7 | 1.7 | 1.46 | 1.39 |
| Quick Ratio(x) | 0.78 | 1.56 | 1.4 | 0.97 | 0.85 | 0.77 | 1.02 | 0.93 | 0.85 | 0.76 | 0.76 |
| Interest Cover(x) | 5.86 | 6.11 | 25.56 | 28.11 | 8.39 | 3.12 | 10.55 | 9.17 | 5.37 | 5.61 | 3.32 |
| Total Debt/Mcap(x) | 0 | 0.03 | 0.02 | 0.05 | 0.15 | 0.33 | 0.33 | 0.33 | 0.42 | 0.22 | 0.31 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 58.95 | 58.95 | 58.75 | 55.63 | 55.63 | 55.48 | 55.03 | 54.87 | 54.87 | 54.87 |
| FII | 8.25 | 8.86 | 8.71 | 9.4 | 7.53 | 7.22 | 6.96 | 7.36 | 6.79 | 7.42 |
| DII | 1.27 | 0.27 | 0.27 | 2.26 | 3.1 | 3.44 | 3.37 | 5.69 | 6.02 | 5.18 |
| Public | 31.53 | 31.92 | 32.27 | 32.71 | 33.74 | 33.87 | 34.64 | 32.08 | 32.33 | 32.53 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 8.16 | 8.16 | 8.13 | 7.7 | 7.7 | 7.68 | 7.62 | 7.59 | 7.59 | 7.59 |
| FII | 1.14 | 1.23 | 1.21 | 1.3 | 1.04 | 1 | 0.96 | 1.02 | 0.94 | 1.03 |
| DII | 0.18 | 0.04 | 0.04 | 0.31 | 0.43 | 0.48 | 0.47 | 0.79 | 0.83 | 0.72 |
| Public | 4.36 | 4.42 | 4.47 | 4.53 | 4.67 | 4.69 | 4.8 | 4.44 | 4.47 | 4.5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +15% | +11% | +14% | +10% |
| Operating Profit CAGR | +4% | +11% | +14% | +8% |
| PAT CAGR | -40% | -21% | +16% | +1% |
| Share Price CAGR | -42% | +8% | -2% | -5% |
| ROE Average | +6% | +8% | +11% | +11% |
| ROCE Average | +8% | +10% | +11% | +13% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 58.95 | 58.95 | 58.75 | 55.63 | 55.63 | 55.48 | 55.03 | 54.87 | 54.87 | 54.87 |
| FII | 8.25 | 8.86 | 8.71 | 9.4 | 7.53 | 7.22 | 6.96 | 7.36 | 6.79 | 7.42 |
| DII | 1.27 | 0.27 | 0.27 | 2.26 | 3.1 | 3.44 | 3.37 | 5.69 | 6.02 | 5.18 |
| Public | 41.05 | 41.05 | 41.25 | 44.37 | 44.37 | 44.52 | 44.97 | 45.13 | 45.13 | 45.13 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 8.16 | 8.16 | 8.13 | 7.7 | 7.7 | 7.68 | 7.62 | 7.59 | 7.59 | 7.59 |
| FII | 1.14 | 1.23 | 1.21 | 1.3 | 1.04 | 1 | 0.96 | 1.02 | 0.94 | 1.03 |
| DII | 0.18 | 0.04 | 0.04 | 0.31 | 0.43 | 0.48 | 0.47 | 0.79 | 0.83 | 0.72 |
| Public | 5.68 | 5.68 | 5.71 | 6.14 | 6.14 | 6.16 | 6.23 | 6.25 | 6.25 | 6.25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 | 13.84 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.